Tehran University of Medical Sciences

Science Communicator Platform

Share By
Rational Design of 3,4,5-Trimethoxyphenyl-Phenoxy-Triazole Derivatives As Highly Potent Α-Glucosidase Inhibitors Publisher



Kermaninia S ; Farina M ; Mahdavi M ; Iraji A
Authors

Source: European Journal of Medicinal Chemistry Reports Published:2026


Abstract

α-Glucosidase inhibitors are essential for better management of postprandial hyperglycemia in patients with type 2 diabetes mellitus. In this context, a novel series of fifteen 3,4,5-trimethoxyphenyl-phenoxy-1,2,3-triazole acetamide hybrids (11a-o) was designed, synthesized, and evaluated for α-glucosidase inhibitory activity. These compounds exhibited strong enzyme inhibition, with IC50 values ranging from 0.15 to 60.41 μM, compared with the positive control, acarbose. Structure-activity relationship (SAR) analysis indicated that the type and position of substituents on the phenyl ring significantly affect potency, with 3-methyl, 2,4-dimethyl and 2,4-dimethoxy groups being the optimal substitutions to improve potency. Compound 11c was the most active analog (IC50 = 0.15 ± 0.01 μM) and exhibits competitive inhibition kinetics. Molecular docking showed that 11c forms multiple stabilizing hydrogen bonds, π-π interactions, and π-cation interactions within the enzyme active site, while molecular dynamics simulations confirmed a stable protein-ligand complex over 100 ns. In silico ADME/T profiling showed good drug likeness, good intestinal absorption, low toxicity prediction, and acceptable pharmacokinetic parameters. Cytotoxicity studies in HEK-293 showed that all derivatives were minimally toxic at the cellular level. In summary, the results show that 3,4,5-trimethoxyphenyl-phenoxy-triazole acetamide hybrids, particularly 11c, are ideal candidates for the future development of potent α-glucosidase inhibitors with a safety profile and oral bioavailability. © 2026 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY license. http://creativecommons.org/licenses/by/4.0/
Related Docs
View other Related Docs
1. Evaluation of Novel 2-(Quinoline-2-Ylthio)Acetamide Derivatives Linked to Diphenyl-Imidazole As Α-Glucosidase Inhibitors: Insights From in Silico, in Vitro, and in Vivo Studies on Their Anti-Diabetic Properties, European Journal of Medicinal Chemistry (2024)
2. Diphenylpiperazine Attached to Different Triazole Acetamide Derivatives As a Potent Α-Glucosidase Inhibitor, New Insight Into the in Silico Study of an Uncompetitive Inhibitor, Journal of Computer-Aided Molecular Design (2026)
3. Synthesis, in Vitro Inhibitor Screening, Structure–Activity Relationship, and Molecular Dynamic Simulation Studies of Novel Thioquinoline Derivatives As Potent Α-Glucosidase Inhibitors, Scientific Reports (2023)
Experts (# of related papers)
View all Related Experts
Somayeh Mojtabavi (14)
Mohammad Mahdavi (14)
Other Related Docs
4. Alpha-Glucosidase Inhibitory and Hypoglycemic Effects of Imidazole-Bearing Thioquinoline Derivatives With Different Substituents: In Silico, in Vitro, and in Vivo Evaluations, Bioorganic Chemistry (2024)
5. Synthesis, in Vitro Potency of Inhibition, Enzyme Kinetics and in Silico Studies of Quinoline-Based Α-Glucosidase Inhibitors, Scientific Reports (2024)
6. Synthesis and Structure–Activity Relationship Studies of Benzimidazole-Thioquinoline Derivatives As Α-Glucosidase Inhibitors, Scientific Reports (2023)
7. Novel N′-Substituted Benzylidene Benzohydrazides Linked to 1,2,3-Triazoles: Potent Α-Glucosidase Inhibitors, Scientific Reports (2023)
8. Design, Synthesis, and Molecular Docking Studies of Diphenylquinoxaline-6-Carbohydrazide Hybrids As Potent Α-Glucosidase Inhibitors, BMC Chemistry (2022)
9. Design, Synthesis, and in Silico Studies of Quinoline-Based-Benzo[D]Imidazole Bearing Different Acetamide Derivatives As Potent Α-Glucosidase Inhibitors, Scientific Reports (2022)
10. Cyanoacetohydrazide Linked to 1,2,3-Triazole Derivatives: A New Class of Α-Glucosidase Inhibitors, Scientific Reports (2022)
11. Synthesis and Bioactivities Evaluation of Quinazolin-4(3H)-One Derivatives As Α-Glucosidase Inhibitors, BMC Chemistry (2022)
12. New Solid Phase Methodology for the Synthesis of Biscoumarin Derivatives: Experimental and in Silico Approaches, BMC Chemistry (2022)
13. Synthesis and Α-Glucosidase Inhibitory Activity of Ethyl 3-Coumarincarboxylate-1,2,3-Triazole-N-Phenylacetamide Derivatives, ChemistrySelect (2026)
14. New Engineered Fusion Peptide With Dual Functionality: Antibacterial and Strong Binding to Hydroxyapatite, International Journal of Peptide Research and Therapeutics (2020)
15. Potent and Selective Α-Glucosidase Inhibition by Coumarin–Triazole Conjugates: Design, in Vivo Evaluation, and Computational Insights, RSC Advances (2026)
16. New Thioxothiazolidinyl-Acetamides Derivatives As Potent Urease Inhibitors: Design, Synthesis, in Vitro Inhibition, and Molecular Dynamic Simulation, Scientific Reports (2023)
17. Design, Synthesis, and in Silico Studies of Benzimidazole Bearing Phenoxyacetamide Derivatives As Α-Glucosidase and Α-Amylase Inhibitors, Journal of Molecular Structure (2022)
18. Synthesis, in Vitro Α-Glucosidase Inhibitory Activities, and Molecular Dynamic Simulations of Novel 4-Hydroxyquinolinone-Hydrazones As Potential Antidiabetic Agents, Scientific Reports (2023)
19. Unveiling the Structure of Gpi-Anchored Protein of Malassezia Globosa and Its Pathogenic Role in Pityriasis Versicolor, Journal of Molecular Modeling (2021)
20. [1,2,4]Triazolo[3,4-B][1,3,4]Thiadiazole Derivatives As New Therapeutic Candidates Against Urease Positive Microorganisms: Design, Synthesis, Pharmacological Evaluations, and in Silico Studies, Scientific Reports (2023)